…including necrotising and fatal cases for GLP-1 receptor agonists and dual GLP-1/GIP receptor agonists
The product information for all Glucagon-Like Peptide-1 (GLP-1) receptor agonists and dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonists has been further updated to highlight the potential risk of severe acute pancreatitis with these products, including rare reports of necrotising and fatal pancreatitis. (Published 29th January 2026)
Please show your support by joining IDDT or renewing your membership now.
We rely on voluntary donations and appreciate any help you can give.
Find out the great benefits of becoming a member.
IDDT has a CONFIDENTIAL Helpline,
find out more.
You don’t have to be a member to donate, you can use the button below to donate via a secure PayPal Donation form. Thank you.
All the money that we raise through the IDDT Lottery goes directly to help people with diabetes and their families.
Find out more.
NICE is an independent organisation responsible for providing national guidance on promoting good health.
InDependent Diabetes Trust
PO Box 294
Northampton
NN1 4XS
UK
01604 622837
An umbrella organisation
All IDDT publications are now accessible via the main Publications menu at the top of the page
